Results 1 to 10 of about 37,951 (172)
New England Journal of Medicine, 1989 Within the last decade, Lyme borreliosis has emerged as a complex new infection whose distribution is worldwide. The disorder is caused by a recently recognized spirochete, B. burgdorferi, transmitted by ticks of the I. ricinus complex. Certain species of mice are critical in the life cycle of the spirochete, and deer appear to be crucial to the tick ...
Allen Steere, Steere Allen C
exaly +15 more sources
Evaluation of standard and modified two-tiered testing algorithms using well-characterized early Lyme disease samples [PDF]
Journal of Clinical MicrobiologyCurrent laboratory testing for Lyme disease (LD) relies on serology. We evaluated the performance of standard two-tiered testing (STTT) and modified two-tiered testing (MTTT) algorithms using samples obtained from well-characterized patients with early ...
Elizabeth J. Horn +8 more
doaj +2 more sources
International Journal of Infectious Diseases, 2022 Purpose: Post-treatment Lyme disease (PTLD) is characterized by patient-reported symptoms after treatment for Borrelia burgdorferi infection. The primary aim of this study was to assess whether participants with a history of Lyme disease (LD) would be ...
John N. Aucott +5 more
doaj +3 more sources
Lyme disease (Lyme borreliosis) [PDF]
FEMS Immunology and Medical Microbiology, 1997 Lyme disease (Lyme borreliosis) has become the most common tick-borne disease in the northern hemisphere. Lyme disease was first described in 1977 by Steere et al. [1]. The town, Old Lyme, CT, USA, was the initial focus of an unusual cluster of juvenile rheumatoid arthritis.
Yasutake Yanagihara +1 more
exaly +3 more sources
Pilot study of psilocybin in patients with post-treatment lyme disease [PDF]
Scientific ReportsLyme disease, caused by the bacterium Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. Although antibiotics effectively treat most cases, an estimated 10–20% of patients develop post-treatment Lyme disease ...
Albert Garcia-Romeu +9 more
doaj +2 more sources
Health care costs, utilization and patterns of care following Lyme disease.
PLoS ONE, 2015 BackgroundLyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of
Emily R Adrion +3 more
doaj +2 more sources
Current Opinion in Pediatrics, 1990 We now have more than 30 years of solid, scientific research about Lyme disease, a relatively common, vector-borne illness in parts of the United States and of Europe. Although there is still widespread misunderstanding of and misinformation about the disease among the lay public, its clinical manifestations as well as how to diagnose and to treat it ...
Dale R, Hamilton, John W, Bachman
+13 more sources
Microorganisms, 2023 Breast cancer is one of the leading causes of death in women worldwide. Recent studies have demonstrated that inflammation due to infections with microorganisms could play a role in breast cancer development.
Ananya Debbarma +4 more
doaj +1 more source
Effect of Invasion of Borrelia burgdorferi in Normal and Neoplastic Mammary Epithelial Cells
Antibiotics, 2021 Borrelia burgdorferi, the causative agent of Lyme Disease, is known to be able to disseminate and colonize various organs and tissues of its hosts, which is very crucial for its pathogenicity and survival.
Gauri Gaur +6 more
doaj +1 more source
Lyme Disease in the Era of COVID-19: A Delayed Diagnosis and Risk for Complications
Case Reports in Infectious Diseases, 2021 We describe a patient with fever and myalgia who did not have COVID-19 but instead had Lyme disease. We propose that the co-occurrence of COVID-19 and Lyme disease during the spring of 2020 resulted in a delayed diagnosis of Lyme disease due to COVID-19 ...
Cheryl B. Novak +2 more
doaj +1 more source